-
Diagnostics World News | Funding for digitizing clinical diagnostics, multi-stage and multi-marker disease testing, tracking viral infections or molecular signatures that indicate the presence of a disease, and more.
Dec 22, 2022
-
Diagnostics World News | The application of sound in diagnostic medicine was among a miscellany of topics on the agenda at the recent Acoustical Society of America meeting in Nashville, Tennessee. These included the use of machine learning to detect diarrhea and pneumonia by listening to, respectively, excretion events and coughs.
Dec 20, 2022
-
Diagnostics World News | Personalis and the University of California, San Francisco have announced a collaboration that will deploy a personalized liquid biopsy-based research use only assay for a study of patients with colorectal cancer.
Dec 15, 2022
-
Diagnostics World News | The National Institutes of Health's All of Us Research Program has begun returning personalized health-related DNA results to more than 155,000 participants, with reports detailing whether participants have an increased risk for specific health conditions and how their body might process certain medications.
Dec 13, 2022
-
Diagnostics World News | Liquid biopsies based on circulating tumor DNA or tumor cells have remarkably improved our prognostic and diagnostic capabilities in oncology. Now, exosome-based liquid biopsies bring the benefits of non-biopsy approaches to a broader range of medical areas.
Dec 9, 2022
-
Diagnostics World News | Researchers have their sights set on creating a first-of-its-kind anatomical map of the vagus nerve. Stavros Zanos of the Feinstein Institutes for Medical Research is leading a three-year-long research study called Reconstructing Vagal Anatomy. The NIH-supported project plans to share the map with the greater scientific community in hopes of leading to new breakthroughs in the field of bioelectronic medicine.
Dec 8, 2022
-
Diagnostics World News | A research team from The Ohio State University and Foundation Medicine suggests that tumor fraction has the potential to serve as a pragmatic, tumor-agnostic prognostic tool. They published their results in Annals of Oncology last month.
Dec 6, 2022